オプションチェーンは、Top Wealth Groupの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Top Wealth Groupの市場センチメントを評価します。.

Top Wealth Group (NASDAQ:TWG) 株価情報, オプションチェーン

Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar.

Top Wealth Group Holding Limited - Ordinary Shares

Top Wealth Group Holding Ltd

<p>JP Morgan  analyst Melissa Wedel   maintains Runway Gwth Fin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) with a Neutral and raises the price target from $10.5 to $11.</p>


News

Price Target

Analyst Ratings

RWAY

JP Morgan Maintains Neutral on Runway Gwth Fin, Raises Price Target to $11

<p>JP Morgan  analyst Tami Zakaria   maintains Middleby (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIDD#NASDAQ">MIDD</a>) with a Underweight and raises the price target from $134 to $145.</p>


MIDD

JP Morgan Maintains Underweight on Middleby, Raises Price Target to $145

<p>JP Morgan  analyst Richard Shane   maintains FS KKR Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) with a Neutral and raises the price target from $20 to $22.</p>


JP Morgan Maintains Neutral on FS KKR Capital, Raises Price Target to $22

WIIM

Olin Corp shares are trading lower after multiple firms cut their respective price targets on the stock.

Trump Trade Adviser Navarro Says It's Going To Take Some Time To Get To Where We Need To Go On Canada

Cleveland-Cliffs shares are trading lower after Morgan Stanley cut its price target on the stock from $13 to $11.

<p>JP Morgan  analyst Anthony Elian   maintains First Hawaiian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>) with a Underweight and raises the price target from $27 to $29.</p>


JP Morgan Maintains Underweight on First Hawaiian, Raises Price Target to $29

<p><strong>Scotiabank </strong>analyst Maher Yaghi downgraded <strong>Comcast Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) from Sector Outperform to Sector Perform and lowered the <a target="_blank" href="https://www.benzinga.com/quote/CMCSA/analyst-ratings" rel="noreferrer noopener">price target from&nbsp;$48&nbsp;to&nbsp;$44.50</a>.</p>
<p>Comcast announced a new strategy to capitalize on the increasing demands for convergence, with a goal of boosting its current 12% wireless/broadband penetration.</p>
<p>In 2025, the company plans to push harder by packaging mobile services with higher-tier broadband products.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43335926/comcast-q4-earnings-beats-estimates-peacock-subscribers-surge-29-dividend-raised-15-billion-buyback-approved" rel="noreferrer noopener">Comcast Q4 Earnings Beat Estimates: Peacock Subscribers Surge 29%, Dividend Raised, $15 Billion Buyback Approved</a></strong></p>
<p>New and select existing broadband customers picking internet speeds of 300MB or higher will receive a free wireless line. While Yaghi noted this could dilute ARPUs, management is optimistic that broadband ARPU growth will remain healthy in 2025. Additionally, the company highlighted a continued focus on network upgrades to support more potent, integrated products across mobile and broadband. Management emphasized offering simplified bundles and pricing structures, a previous pain point, for new and existing customers.</p>
<p>Comcast reported 139K in domestic broadband losses during the quarter (versus -34K previous year), worse than Yaghi&#8217;s -105K and consensus of -95K. As management highlighted in the previous quarter, weak loading was likely due to impacts from the two hurricanes, which have adversely affected their cable systems and the seasonal tailwind of viewers returning to the Southeast.</p>
<p>Broadband continues to operate in a very competitive market as it competes with fiber and FWA offerings. Still, the company expects the new broadband/mobile converged strategy, as discussed above, to help acquire new customers and retain existing ones. The offering has yet to be rolled out nationwide, so Yaghi does not expect the first half of 2025 net adds to show any material improvement.</p>
<p>Yahi noted that Comcast is growing faster than many peers due to three of its profitable and growing business units. The analyst also noted that fiber competition from incumbents is unlikely to cause significant pain in the short to medium term in the U.S. and that wireless could be the biggest driver for the stock in the medium to long term.</p>
<p>He also noted that its theme parks and media assets are cyclical and exposed to U.S. economic weakness. However, considering the relatively small size of these assets, Yaghi mentioned that Comcast has already priced in some risks, given the stock&#8217;s currently low multiples.</p>
<p>Comcast bleeds broadband customers due to Fixed Wireless Access&nbsp;(FWA) and increasing fiber competition.</p>
<p>Comcast intends to begin offering combo plans to customers using the internet at speeds above those provided by FWA services, with a free wireless line as a retention tool to protect market share.</p>
<p>While this strategy will dilute ARPU and margins, management expects to garner lowered churn rates on broadband as a result.</p>
<p>The U-turn on broadband strategy will likely pressure FCF generation and is not guaranteed to protect broadband market share in the long term.</p>
<p>As a result of this more aggressive pricing strategy, Yaghi reduced his multiple to the connectivity business from 7.0 to 6.5x, resulting in a lowered target price and rating. The analyst expects the stock to remain pressured until markets see signs of stabilization on broadband loading.</p>
<p>Yaghi projected first-quarter revenue of $29.97 billion and adjusted EPS of $1.02.</p>
<p><strong>CMCSA Price Action: </strong>Comcast stock was down 0.88% at $33.37 at the last check Monday.</p>
<p><strong>Also Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/01/43390140/charter-q4-earnings-beats-estimates-mobile-growth-surges-with-529k-new-lines-despite-broadband-subscriber-losses" target="_blank" rel="noreferrer noopener">Charter Beats Earnings Estimates: Mobile Growth Surges, Broadband Subscriber Losses, Network Investments, Mobile &amp; Ad Sales Increase</a></strong></li>
</ul>
<p><em>Photo via Shutterstock.</em></p>


Analyst Color

Equities

Downgrades

Trading Ideas

CMCSA

Comcast Faces Broadband Headwinds, Analyst Downgrades Stock And Cuts Price Forecast

<p>JP Morgan  analyst Jeffrey Zekaukas   maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Overweight and raises the price target from $110 to $112.</p>


JP Morgan Maintains Overweight on Eastman Chemical, Raises Price Target to $112

<p><strong>LyondellBasell Industries N.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) reported better-than-expected fourth-quarter 2024 <a href="https://www.benzinga.com/quote/lyb/earnings">sales on Friday</a>.</p>
<p>LyondellBasell reported revenues of $9.497 billion, down 4.4% year-over-year and above the consensus of $9.225 billion. Adjusted EPS was at 75 cents, which is in-line with the consensus.</p>
<p>"The volumes of our sustainable products are rapidly growing and aligned with our profitability targets. We are sharpening our focus on value creation while diligently managing and tracking our progress through a highly disciplined Value Enhancement Program. With a robust investment-grade balance sheet, LYB is well-positioned to deliver on our strategic promises and reward shareholders with a growing dividend as part of our overall value proposition," commented LyondellBasell CEO Peter Vanacker.</p>
<p>For 2025, the company said it anticipates seasonal demand improvements in the first quarter of 2025, supported by lower interest rates, moderate inflation, and rising durable goods consumption.</p>
<p>The company aligns operations with global demand, expecting Olefins &amp; Polyolefins Americas at 80%, EAI at 75% and Intermediates &amp; Derivatives at 80%.</p>
<p>LyondellBasell shares fell 0.2% to trade at $75.53 on Monday.</p>
<p>These analysts made changes to their price targets on LyondellBasell following earnings announcement.</p>
<ul>
<li>Wells Fargo analyst Michael Sison maintained LyondellBasell with an Overweight and lowered the price target from $95 to $90.</li>
<li>UBS analyst Joshua Spector maintained LyondellBasell with a Neutral and lowered the price target from $77 to $76.</li>
<li>Barclays analyst Michael Leithead maintained the stock with an Equal-Weight and cut the price target from $90 to $80.</li>
</ul>
<p><strong>Considering buying LYB stock? Here&#8217;s what analysts think: </strong></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="601" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-1024x601.png" alt="" class="wp-image-763207" style="width:537px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-1024x601.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1-768x451.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03132838/image-2-1.png 1101w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields"><strong>Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</strong></a></li>
</ul>


Earnings

These Analysts Slash Their Forecasts On LyondellBasell Industries After Q4 Results

<p>JP Morgan  analyst Melissa Wedel   maintains Carlyle Secured Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBD#NASDAQ">CGBD</a>) with a Underweight and raises the price target from $16 to $17.</p>


CGBD

JP Morgan Maintains Underweight on Carlyle Secured Lending, Raises Price Target to $17

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>AbbVie</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 24 uncommon options trades for AbbVie.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $105,465, and 21 are calls, for a total amount of $1,655,712.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $210.0 for AbbVie over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $150.0 to $210.0 in the last 30 days. </p>
<h3>AbbVie Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607428_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$4.7</td>
<td>$4.55</td>
<td>$4.56</td>
<td>$195.00</td>
<td>$615.5K</td>
<td align="right">546</td>
<td>1.4K</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$15.5</td>
<td>$14.2</td>
<td>$15.3</td>
<td>$175.00</td>
<td>$84.1K</td>
<td align="right">225</td>
<td>171</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$16.1</td>
<td>$14.6</td>
<td>$15.15</td>
<td>$175.00</td>
<td>$83.3K</td>
<td align="right">225</td>
<td>61</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$10.9</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$180.00</td>
<td>$77.7K</td>
<td align="right">529</td>
<td>22</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$16.85</td>
<td>$16.2</td>
<td>$16.58</td>
<td>$172.50</td>
<td>$72.9K</td>
<td align="right">200</td>
<td>45</td>
</tr>
</tbody>
</table>
</p>
<h3>About AbbVie</h3>
<p>AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).</p>
<p>Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of AbbVie</h3>
<ul>
<li>Trading volume stands at 4,545,253, with ABBV's price up by 3.15%, positioned at $189.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 81 days.</li>
</ul>
<h3>What Analysts Are Saying About AbbVie</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $208.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $220.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on AbbVie with a target price of $190.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $211.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $205.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on AbbVie with a target price of $217. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for AbbVie, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

ABBV

Looking At AbbVie's Recent Unusual Options Activity

<p>High-rolling investors have positioned themselves bullish on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in DHR often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 13 options trades for Danaher. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 61% bullish and 38% bearish. Among all the options we identified, there was one put, amounting to $26,400, and 12 calls, totaling $9,798,273.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $240.0 for Danaher, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Danaher stands at 1815.33, with a total volume reaching 6,881.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Danaher, situated within the strike price corridor from $220.0 to $240.0, throughout the last 30 days.</p>
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607423_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$28.6</td>
<td>$27.3</td>
<td>$28.6</td>
<td>$240.00</td>
<td>$7.8M</td>
<td>2.5K</td>
<td>3.4K</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$30.1</td>
<td>$26.5</td>
<td>$29.9</td>
<td>$240.00</td>
<td>$299.0K</td>
<td>2.5K</td>
<td>0</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.6</td>
<td>$27.4</td>
<td>$29.6</td>
<td>$240.00</td>
<td>$296.0K</td>
<td>2.5K</td>
<td>300</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.4</td>
<td>$28.3</td>
<td>$29.4</td>
<td>$240.00</td>
<td>$294.0K</td>
<td>2.5K</td>
<td>630</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$29.4</td>
<td>$28.2</td>
<td>$29.4</td>
<td>$240.00</td>
<td>$294.0K</td>
<td>2.5K</td>
<td>510</td>
</tr>
</tbody>
</table>
</p>
<h3>About Danaher</h3>
<p>In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.</p>
<p>After a thorough review of the options trading surrounding Danaher, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Danaher</h3>
<ul>
<li>Currently trading with a volume of 2,405,344, the DHR's price is down by -2.51%, now at $217.16. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 78 days.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $256.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Jefferies persists with their Buy rating on Danaher, maintaining a target price of $260.<br />
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Danaher, which currently sits at a price target of $258.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Danaher with a target price of $240.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Danaher, which currently sits at a price target of $240.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on Danaher, maintaining a target price of $285. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Danaher with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Danaher's Options: A Look at What the Big Money is Thinking

<p>Financial giants have made a conspicuous bullish move on RH. Our analysis of options history for RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) revealed 15 unusual trades.</p>
<p>Delving into the details, we found 40% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $404,855, and 7 were calls, valued at $397,165.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $125.0 to $600.0 for RH over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of RH stands at 126.6, with a total volume reaching 554.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in RH, situated within the strike price corridor from $125.0 to $600.0, throughout the last 30 days.</p>
<h3>RH 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738607418_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$3.7</td>
<td>$3.3</td>
<td>$3.7</td>
<td>$385.00</td>
<td>$104.7K</td>
<td align="right">70</td>
<td align="right">93</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$13.7</td>
<td>$13.1</td>
<td>$13.1</td>
<td>$390.00</td>
<td>$94.3K</td>
<td align="right">1</td>
<td align="right">149</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$31.0</td>
<td>$26.0</td>
<td>$31.0</td>
<td>$600.00</td>
<td>$93.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$14.8</td>
<td>$14.0</td>
<td>$14.1</td>
<td>$402.50</td>
<td>$70.1K</td>
<td align="right">0</td>
<td align="right">100</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$36.4</td>
<td>$35.5</td>
<td>$36.4</td>
<td>$350.00</td>
<td>$65.5K</td>
<td align="right">43</td>
<td align="right">18</td>
</tr>
</tbody>
</table>
</p>
<h3>About RH</h3>
<p>RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 19 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in bespoke furniture, architecture, media, and more.</p>
<p>In light of the recent options history for RH, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>RH's Current Market Status</h3>
<ul>
<li>Trading volume stands at 592,123, with RH's price down by -3.92%, positioned at $402.68.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 51 days.</li>
</ul>
<h3>What Analysts Are Saying About RH</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $473.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays upgraded its action to Overweight with a price target of $515.<br />
&#x2A; In a positive move, an analyst from Morgan Stanley has upgraded their rating to Overweight and adjusted the price target to $530.<br />
&#x2A; Showing optimism, an analyst from Goldman Sachs upgrades its rating to Neutral with a revised price target of $374. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest RH options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


RH's Options: A Look at What the Big Money is Thinking

<p>JP Morgan  analyst Puneet Jain   maintains Broadridge Financial Soln (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) with a Neutral and raises the price target from $231 to $249.</p>


JP Morgan Maintains Neutral on Broadridge Financial Soln, Raises Price Target to $249

HWKN

Hawkins shares are trading higher after the company announced the acquisition of Amerochem Corporation.

<p>JP Morgan  analyst Melissa Wedel   maintains Blackstone Secured (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXSL#NYSE">BXSL</a>) with a Overweight and raises the price target from $33 to $33.5.</p>


BXSL

JP Morgan Maintains Overweight on Blackstone Secured, Raises Price Target to $33.5

<p>JP Morgan  analyst Melissa Wedel   maintains Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) with a Overweight and raises the price target from $23 to $24.5.</p>


ARCC

JP Morgan Maintains Overweight on Ares Capital, Raises Price Target to $24.5

China's UN Envoy Says We Need Cooperation On AI, Particularly Between China, U.S., Fragmentation Will Only Enhance Risk And Reduce Benefits

Top Wealth Group files to sell 27M ordinary shares

Top Wealth Group announces pricing of $10.8M public offering; shares jump

In this video, I review some amazing trades, one missed entry non-trade, a losing trade, and how not taking a high conviction trade can ruin them all.

A Lot Of Home Runs And One Ugly Strikeout; One New Swing Position

Top Wealth Group Holding Limited (TWG) has released an update. Top Wealth Group Holding Limited has appointed AC Sunshine Securities LLC as its exc...

Top Wealth Group Partners for Share Placement

09:46 EDT Top Wealth Group (TWG) Holding Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Top Wealth Group Holding Ltd trading resumes

In this video, I provide some data points that seem to suggest that traders should expect some choppy/volatile price action in the short-term.

Short-Term Concerns Arise; One New Swing Position For Next Week

Top Wealth Group receives Nasdaq notification letter regarding minimum bid price deficiency

Top Wealth Group (TWG) announced that it received a delinquency notification letter from the Listing Qualifications Department of The Nasdaq Stock ...

Top Wealth Group announces receipt of Nasdaq notification letter on deficiency

Top Wealth Group Holding Limited ( ($TWG) ) has issued an update. Top Wealth Group Holding Limited reported a significant decline in revenue by 36....

Top Wealth Group Announces 2024 First Half Financial Results Amid Revenue Decline

Top Wealth Group Holding Limited ( ($TWG) ) has provided an announcement. Top Wealth Group Holding Limited, a company with its principal executive ...

Comments

Top Wealth Group

Top Wealth Group (TWG) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル